![](/img/cover-not-exists.png)
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
Emery, P., Burmester, G. R., Bykerk, V. P., Combe, B. G., Furst, D. E., Barre, E., Karyekar, C. S., Wong, D. A., Huizinga, T. W. J.Volume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-206106
Date:
January, 2015
File:
PDF, 1.72 MB
english, 2015